Narrow search
Showing 1 - 10 of 380
Cover Image
How Effective are Advertising Bans? On the Demand for Quality in Two-Sided Media Markets
Greiner, Tanja - 2011
advertising motive. We analyze the impact of both the strength of mutual externalities and advertisement regulation policies on …
Persistent link: https://www.econbiz.de/10013122127
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt Richard - 2015
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a … that the effects of stricter price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the distributor, price regulation counteracts this effect …
Persistent link: https://www.econbiz.de/10013017702
Cover Image
Net Neutrality and Internet Fragmentation : The Role of Online Advertising
D'Annunzio, Anna - 2015
We investigate the relation between Net Neutrality regulation and Internet fragmentation. We model a two-sided market …
Persistent link: https://www.econbiz.de/10013017710
Cover Image
Asymmetric Innovation Agreements Under Environmental Regulation
Aoyama, Naoto - 2018
In a domestic market, a duopoly produces a homogeneous final good, pollution, pollution abatement and R&D. One of the firms (foreign) has superior technology. The government regulates the duopoly by levying a pollution tax to maximize domestic welfare. We consider the potential implementation of...
Persistent link: https://www.econbiz.de/10012928255
Cover Image
Competition and Quality in Regulated Markets with Sluggish Demand
Brekke, Kurt Richard - 2010
We investigate the effect of competition on quality in regulated markets (e.g., health care, higher education, public utilities), using a Hotelling framework, in the presence of sluggish demand. We take a differential-game approach, and derive the open-loop solution (providers choose the optimal...
Persistent link: https://www.econbiz.de/10013148292
Cover Image
Reference Pricing of Pharmaceuticals
Brekke, Kurt Richard; Königbauer, Ingrid; Straume, Odd Rune - 2021
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10013317373
Cover Image
How Effective are Advertising Bans? On the Demand for Quality in Two-Sided Media Markets
Greiner, Tanja; Sahm, Marco - CESifo - 2011
advertising motive. We analyze the impact of both the strength of mutual externalities and advertisement regulation policies on …
Persistent link: https://www.econbiz.de/10009221558
Cover Image
Unbundling the Incumbent and Entry Into Fiber : Evidence From France
Bourreau, Marc - 2018
We use panel data on 36,104 municipalities in metropolitan France over the period 2010-2014 to estimate two models of entry into local markets by: (i) alternative operators using wholesale access to the legacy copper network via local loop unbundling (LLU), and (ii) the incumbent and two...
Persistent link: https://www.econbiz.de/10012916532
Cover Image
Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?
Brekke, Kurt R.; Grasdal, Astrid L.; Holmås, Tor Helge - CESifo - 2007
-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … dataset, covering the drugs exposed to RP and a large number of drugs still under PC regulation in the time before and after … regulation in lowering drug prices, while the cross-price effect raises a concern about patent protection. …
Persistent link: https://www.econbiz.de/10005406112
Cover Image
Reference Pricing of Pharmaceuticals
Brekke, Kurt R.; Königbauer, Ingrid; Straume, Odd Rune - CESifo - 2006
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10005406396